Growth inhibition of androgen-responsive prostate cancer cells with brefeldin A targeting cell cycle and androgen receptor

Growth inhibition of androgen-responsive prostate cancer cells with brefeldin A targeting cell cycle and androgen receptor

<p>Abstract</p> <p>Background</p> <p>Androgen ablation is one of the viable therapeutic options for patients with primary hormone (androgen)-dependent prostate cancer. However, an antibiotic brefeldin A (BFA) has been shown to exhibit the growth inhibitory effect on hum...

Full description

Bibliographic Details
Main Authors: Choudhury Muhammad, Aynehchi Shahrad, Alonzo Catherine, Rajamahanty Srinivas, Konno Sensuke
Format: Article
Language:English
Published: BMC 2010-01-01
Series:Journal of Biomedical Science
Online Access:http://www.jbiomedsci.com/content/17/1/5

Similar Items

Similar Items